Q&A: How AI and ML are reshaping the research landscape

Sponsored content By Panalgo

In a rapidly evolving landscape where artificial intelligence (AI) and machine learning (ML) have become household terms, their impact on biopharmaceutical research and epidemiology is profound. I caught up with Mike Munsell, PhD, Director of Research at Panalgo, to discuss how these technologies are transforming the healthcare research landscape and their real-world applications in biopharmaceutical R&D. Classically trained epidemiologists know more about ML and AI than they think they do, and here’s why.

Q: We’re hearing more about AI, ML, and ChatGPT these days. Can you give me a definition of what each is and how they might overlap?

A: With AI, computers are essentially mimicking human decision-making. ML, a subdiscipline of AI, uses algorithms...

Today's Sponsors

Today's Sponsor